ArticleTranslational lung cancer research2024

Phase Ib/II study of imprime PGG and pembrolizumab in patients with previously treated advanced non-small cell lung cancer (NSCLC): BTCRC LUN 15-017.

Muhammad Furqan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.